Platelet-inhibitors in patients with acute coronary syndrome
Mortality rate in patients with ST elevated myocardial infarction (STEMI) has dramatically decreased during the last 20 years in France (Figure).1New drugs are not the main part of this evolution.They have to be considered as a part of the global French management of patients with acute coronary syndrome.Three points have to be considered.
FrédéricLapostolle JéromeMourad FrédéricAdnet TomislavPetrovic
SAMU 93-UF Recherche-Enseignement-Qualité Université Paris 13,Sorbonne Paris Cité,EA 3509 H(o)pital Avicenne,125,rue de Stalingrad,93009,Bobigny,France
国内会议
北京
英文
8-9
2014-04-11(万方平台首次上网日期,不代表论文的发表时间)